Personalized Blood Thinner Therapy After Heart Stent
Part of Heart & circulation clinical trials.
This study tests whether genetic testing can help doctors choose the best blood thinner for you after receiving a stent (a small tube) in your heart artery. The goal is to find which medication works best for your body to prevent clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have recently had or are planning to have a stent placed in a heart artery (called PCI with stenting)
- You are able to take ticagrelor (a blood thinner medication)
- You are able to take clopidogrel (another blood thinner medication)
- You can provide a cheek swab sample (buccal swab) for genetic testing
- Your doctors expect you to survive at least 48 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
This study looks at whether choosing blood thinners based on each person's needs works better than a standard approach after getting a heart stent. It aims to reduce risks like blood clots or bleeding.
This study tests whether using a genetic test to choose your blood thinner (clopidogrel or ticagrelor) can improve how well the medication works. You may qualify if you have stable heart disease or a recent heart attack and are scheduled for a stent procedure.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial compares two ways to choose blood thinners after a heart attack in people at high risk for bleeding. One way uses a genetic test to guide the choice, while the other uses a different approach.
Hear when a new High Risk Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.